| Tatiana Mckenna, MD | |
|
1 Capital Way, Pennington, NJ 08534-2520 | |
| (609) 303-4000 | |
| Not Available |
| Full Name | Tatiana Mckenna |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 1 Capital Way, Pennington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376806083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA09758900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Multispecialty Group | 1850689894 | 233 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The world's largest retailer and largest private employer announced Tuesday that it would terminate health insurance coverage for employees who work fewer than an average of 30 hours a week.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) - which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) - finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
› Verified 8 days ago
| Entity Name | State Of New Jersey Omb Centralized Payroll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467552240 PECOS PAC ID: 6406742592 Enrollment ID: O20050603000317 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The world's largest retailer and largest private employer announced Tuesday that it would terminate health insurance coverage for employees who work fewer than an average of 30 hours a week.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) - which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) - finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
› Verified 8 days ago
| Entity Name | Mercer Internists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174565964 PECOS PAC ID: 2860647039 Enrollment ID: O20130220000156 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The world's largest retailer and largest private employer announced Tuesday that it would terminate health insurance coverage for employees who work fewer than an average of 30 hours a week.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) - which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) - finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
› Verified 8 days ago
| Entity Name | Capital Health Multispecialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083072342 PECOS PAC ID: 1850689894 Enrollment ID: O20161007000162 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The world's largest retailer and largest private employer announced Tuesday that it would terminate health insurance coverage for employees who work fewer than an average of 30 hours a week.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) - which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) - finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tatiana Mckenna, MD 750 Brunswick Ave, Trenton, NJ 08638-4143 Ph: (609) 394-6031 | Tatiana Mckenna, MD 1 Capital Way, Pennington, NJ 08534-2520 Ph: (609) 303-4000 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The world's largest retailer and largest private employer announced Tuesday that it would terminate health insurance coverage for employees who work fewer than an average of 30 hours a week.
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
NUI Galway has been awarded a major new €6 million European project, designed to address complications associated with diabetes. The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.
Hispanic Community Health Study/Study of Latinos (HCHS-SOL) - which will be presented at the American Heart Association Annual Meeting in Los Angeles on Nov. 5 and published in the Nov. 7 issue of the Journal of the American Medical Association (JAMA) - finds heart disease risk factors are widespread among Hispanic/Latino adults in the United States.
› Verified 8 days ago
Neil Saxena, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 385, Pennington, NJ 08534 Phone: 609-303-4838 Fax: 609-303-4835 | |
Madhuri Adabala, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Mowyad Omer Elamin Khalid, M.D Internal Medicine Medicare: Medicare Enrolled Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 Fax: 609-303-4361 | |
Rishi Patel, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 | |
Dr. Brian Adam Meltzer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6 E Acres Dr, Pennington, NJ 08534 Phone: 609-737-1903 Fax: 732-247-5309 | |
Marie Antoinette Marquez, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1300 Merrill Lynch Dr, Pennington, NJ 08534 Phone: 609-274-6000 | |
Anita Maraj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 |